Cara Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.188; its P/E ratio is -0.32; Cara Therapeutics is scheduled to report earnings on May 6, 2024, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 4.87M	$ 5.41M	$ 6.17M	$ 3.26M	$ 10.81M
Gross Profit	$ 4.87M	$ 6.93M	$ 6.17M	$ 3.26M	$ 7.76M
EBIT	$ -24.92M	$ -28.64M	$ -26.66M	$ -30.34M	$ -23.84M
EBITDA	$ -24.50M	$ -28.16M	$ -26.33M	$ -30.14M	$ -23.78M
Net Income Common Stockholders	$ -24.92M	$ -31.48M	$ -26.66M	$ -30.34M	$ -23.18M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 78.54M	$ 95.10M	$ 47.80M	$ 64.15M	$ 155.61M
Total Assets	$ 115.34M	$ 134.39M	$ 153.28M	$ 182.24M	$ 213.51M
Total Debt	$ 7.31M	$ 982.00K	$ 77.42M	$ 94.93M	$ 2.37M
Net Debt	$ -71.23M	$ -94.12M	$ 29.62M	$ 30.78M	$ -153.24M
Total Liabilities	$ 29.70M	$ 25.46M	$ 92.64M	$ 116.47M	$ 28.69M
Stockholders Equity	$ 85.64M	$ 108.93M	$ 136.60M	$ 158.78M	$ 184.82M
Cash Flow	-
Free Cash Flow	$ -19.97M	$ -20.45M	$ -34.62M	$ -23.51M	$ -25.19M
Operating Cash Flow	$ -19.64M	$ -20.45M	$ -34.62M	$ -23.51M	$ -25.19M
Investing Cash Flow	$ 23.16M	$ 32.80M	$ 17.71M	$ 44.42M	$ 21.18M
Financing Cash Flow	$ 1.12M	-	$ 560.00K	$ 22.00K	$ 104.00K

Currency in USD

Cara Therapeutics Earnings and Revenue History

Income Statement >

Cara Therapeutics Debt to Assets

Balance Sheet >

Cara Therapeutics Cash Flow

Cash Flow >

Cara Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing